Krystal A. Huey

Krystal A. Huey currently serves as the Director of Global Value Access & Pricing and Amyloidosis Franchise Lead at Alexion Pharmaceuticals, Inc., where responsibilities include overseeing global value and access strategies in multiple therapeutic areas. Prior experience includes roles at Celgene focused on value, access, and health economics in hematology, and a research internship at Northeastern University's mHealth Research Group. Clinical rotations at Boston Medical Center provided exposure to family medicine and hematology/oncology. Earlier positions included research at the University of California, San Francisco’s TRANSPERS, and roles at Brain Power LLC and Novartis Institutes for BioMedical Research. Krystal A. Huey earned a Master of Science in Health Outcomes, Policy, and Economics from Rutgers University and a Doctor of Pharmacy from Northeastern University.